Association of metabolic syndrome and lifestyle factors with lower urinary tract symptoms and benign prostatic hyperplasia
Keywords:
Metabolic Syndrome, Lower Urinary Tract Symptoms, Lifestyle Factors, Prostatic Hyperplasia, HyperplasiaAbstract
Objective: The study aimed to find out how often people with urinary problems also have metabolic syndrome and benign prostatic hyperplasia. It also looked at how lifestyle choices might be linked to these urinary issues. Methods: This was a cross-sectional study carried out at the Shaikha Fatima Institute of Nursing and Health Sciences in Lahore from May to December 2022. It involved 150 participants, and data analysis was done using Statistical Package for Social Sciences version 22.0. Results: The result of study revealed that mean± SD of age and BMI was 43±14.23 and23±5.2 respectively. Most common symptom was UTI which was present in 93(62.0%) of cases followed by urinary urgency 58(38.7%), and BPH 57(38.0%). About 43(28.7%) patients with LUTS had metabolic syndrome. Significant association of metabolic syndrome was found with urinary incontinence, burning micturition, urinary urgency, UTI and BPH. The life style factors were also associated with metabolic syndrome. Significant association was found between metabolic syndrome and stressful life, alcohol consumption, consumption of vegetables and fat content in diet >2tbsp/ day, and sedentary working environment. Conclusion: The study concluded that metabolic syndrome was linked to lower urinary tract symptoms (LUTS) and benign prostatic hyperplasia (BPH).
Downloads
References
Lee C-L, Kuo H-C. Pathophysiology of benign prostate enlargement and lower urinary tract symptoms: Current concepts. Tzu Chi Medical Journal. 2017;29(2):79-83.
Parsons JK. Benign prostatic hyperplasia and male lower urinary tract symptoms: epidemiology and risk factors. Current bladder dysfunction reports. 2010;5:212-8.
Stanciu S, Rusu E, Miricescu D, Radu AC, Axinia B, Vrabie AM, et al. Links between metabolic syndrome and hypertension: the relationship with the current antidiabetic drugs. Metabolites. 2023;13(1):87.
Ngai H-Y, Yuen K-KS, Ng C-M, Cheng C-H, Chu S-KP. Metabolic syndrome and benign prostatic hyperplasia: an update. Asian Journal of Urology. 2017;4(3):164-73.
Rył A, Rotter I, Miazgowski T, Słojewski M, Dołęgowska B, Lubkowska A, et al. Metabolic syndrome and benign prostatic hyperplasia: association or coincidence? Diabetology & metabolic syndrome. 2015;7:1-7.
Parsons J. Lifestyle factors, benign prostatic hyperplasia, and lower urinary tract symptoms. Current opinion in urology. 2011;21(1):1-4.
Mathey LIP. Benign prostatic hyperplasia: epidemiology, pathophysiology, and clinical manifestations. Molecular Mechanisms in Cancer: IntechOpen; 2022.
Tylutka A, Morawin B, Walas Ł, Michałek M, Gwara A, Zembron-Lacny A. Assessment of metabolic syndrome predictors in relation to inflammation and visceral fat tissue in older adults. Scientific Reports. 2023;13(1):89.
Alipour P, Azizi Z, Raparelli V, Norris CM, Kautzky-Willer A, Kublickiene K, et al. Role of sex and gender-related variables in development of metabolic syndrome: A prospective cohort study. European Journal of Internal Medicine. 2024;121:63-75.
Ahima RS. Overview of metabolic syndrome. Metabolic syndrome: a comprehensive textbook: Springer; 2024. p. 3-14.
Cankurtaran M, Halil M, Yavuz BB, Dagli N, Oyan B, Ariogul S. Prevalence and correlates of metabolic syndrome (MS) in older adults. Archives of gerontology and geriatrics. 2006;42(1):35-45.
Felisatti F. Lifestyle factors and their association with neuroimaging and cognitive markers of aging and Alzheimer’s disease: influence of cardiovascular risk factors, APOE4 genotype and effect of a meditation intervention: Normandie; 2023.
Published
How to Cite
Issue
Section
Copyright (c) 2023 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.
